BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 14502435)

  • 1. Comparative pharmacology of the activity of wild-type and G551D mutated CFTR chloride channel: effect of the benzimidazolone derivative NS004.
    Dérand R; Bulteau-Pignoux L; Becq F
    J Membr Biol; 2003 Jul; 194(2):109-17. PubMed ID: 14502435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The substituted benzimidazolone NS004 is an opener of the cystic fibrosis chloride channel.
    Gribkoff VK; Champigny G; Barbry P; Dworetzky SI; Meanwell NA; Lazdunski M
    J Biol Chem; 1994 Apr; 269(15):10983-6. PubMed ID: 7512555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of pyrrolo[2,3-b]pyrazines derivatives as submicromolar affinity activators of wild type, G551D, and F508del cystic fibrosis transmembrane conductance regulator chloride channels.
    Noel S; Faveau C; Norez C; Rogier C; Mettey Y; Becq F
    J Pharmacol Exp Ther; 2006 Oct; 319(1):349-59. PubMed ID: 16829626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G551D and G1349D, two CF-associated mutations in the signature sequences of CFTR, exhibit distinct gating defects.
    Bompadre SG; Sohma Y; Li M; Hwang TC
    J Gen Physiol; 2007 Apr; 129(4):285-98. PubMed ID: 17353351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cystic fibrosis mutation G551D alters the non-Michaelis-Menten behavior of the cystic fibrosis transmembrane conductance regulator (CFTR) channel and abolishes the inhibitory Genistein binding site.
    Derand R; Bulteau-Pignoux L; Becq F
    J Biol Chem; 2002 Sep; 277(39):35999-6004. PubMed ID: 12124395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The glycine residues G551 and G1349 within the ATP-binding cassette signature motifs play critical roles in the activation and inhibition of cystic fibrosis transmembrane conductance regulator channels by phloxine B.
    Melin P; Norez C; Callebaut I; Becq F
    J Membr Biol; 2005 Dec; 208(3):203-12. PubMed ID: 16604470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A common mechanism for cystic fibrosis transmembrane conductance regulator protein activation by genistein and benzimidazolone analogs.
    Al-Nakkash L; Hu S; Li M; Hwang TC
    J Pharmacol Exp Ther; 2001 Feb; 296(2):464-72. PubMed ID: 11160632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cystic fibrosis mutation G1349D within the signature motif LSHGH of NBD2 abolishes the activation of CFTR chloride channels by genistein.
    Melin P; Thoreau V; Norez C; Bilan F; Kitzis A; Becq F
    Biochem Pharmacol; 2004 Jun; 67(12):2187-96. PubMed ID: 15163550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of alpha-aminoazaheterocycle-methylglyoxal adducts as a new class of high-affinity inhibitors of cystic fibrosis transmembrane conductance regulator chloride channels.
    Routaboul C; Norez C; Melin P; Molina MC; Boucherle B; Bossard F; Noel S; Robert R; Gauthier C; Becq F; Décout JL
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1023-35. PubMed ID: 17578899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanosensitivity of wild-type and G551D cystic fibrosis transmembrane conductance regulator (CFTR) controls regulatory volume decrease in simple epithelia.
    Xie C; Cao X; Chen X; Wang D; Zhang WK; Sun Y; Hu W; Zhou Z; Wang Y; Huang P
    FASEB J; 2016 Apr; 30(4):1579-89. PubMed ID: 26683699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic fibrosis transmembrane conductance regulator activation by cAMP-independent mechanisms.
    He Z; Raman S; Guo Y; Reenstra WW
    Am J Physiol; 1998 Oct; 275(4):C958-66. PubMed ID: 9755049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of disease-associated cystic fibrosis transmembrane conductance regulator mutants by hydrolyzable ATP analogs.
    Miki H; Zhou Z; Li M; Hwang TC; Bompadre SG
    J Biol Chem; 2010 Jun; 285(26):19967-75. PubMed ID: 20406820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genistein modifies the activation kinetics and magnitude of phosphorylated wild-type and G551D-CFTR chloride currents.
    Bulteau-Pignoux L; Dérand R; Métayé T; Joffre M; Becq F
    J Membr Biol; 2002 Aug; 188(3):175-82. PubMed ID: 12181609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin and genistein additively potentiate G551D-CFTR.
    Yu YC; Miki H; Nakamura Y; Hanyuda A; Matsuzaki Y; Abe Y; Yasui M; Tanaka K; Hwang TC; Bompadre SG; Sohma Y
    J Cyst Fibros; 2011 Jul; 10(4):243-52. PubMed ID: 21441077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genistein improves regulatory interactions between G551D-cystic fibrosis transmembrane conductance regulator and the epithelial sodium channel in Xenopus oocytes.
    Suaud L; Carattino M; Kleyman TR; Rubenstein RC
    J Biol Chem; 2002 Dec; 277(52):50341-7. PubMed ID: 12386156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenylglycine and sulfonamide correctors of defective delta F508 and G551D cystic fibrosis transmembrane conductance regulator chloride-channel gating.
    Pedemonte N; Sonawane ND; Taddei A; Hu J; Zegarra-Moran O; Suen YF; Robins LI; Dicus CW; Willenbring D; Nantz MH; Kurth MJ; Galietta LJ; Verkman AS
    Mol Pharmacol; 2005 May; 67(5):1797-807. PubMed ID: 15722457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capsaicin potentiates wild-type and mutant cystic fibrosis transmembrane conductance regulator chloride-channel currents.
    Ai T; Bompadre SG; Wang X; Hu S; Li M; Hwang TC
    Mol Pharmacol; 2004 Jun; 65(6):1415-26. PubMed ID: 15155835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of VX-770 (ivacaftor) and OAG on Ca2+ influx and CFTR activity in G551D and F508del-CFTR expressing cells.
    Vachel L; Norez C; Becq F; Vandebrouck C
    J Cyst Fibros; 2013 Dec; 12(6):584-91. PubMed ID: 23757361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic fibrosis transmembrane conductance regulator (CFTR) confers glibenclamide sensitivity to outwardly rectifying chloride channel (ORCC) in Hi-5 insect cells.
    Julien M; Verrier B; Cerutti M; Chappe V; Gola M; Devauchelle G; Becq F
    J Membr Biol; 1999 Apr; 168(3):229-39. PubMed ID: 10191357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cAMP- and Ca2+-independent activation of cystic fibrosis transmembrane conductance regulator channels by phenylimidazothiazole drugs.
    Becq F; Verrier B; Chang XB; Riordan JR; Hanrahan JW
    J Biol Chem; 1996 Jul; 271(27):16171-9. PubMed ID: 8663098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.